XML 16 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Operating expenses:        
Research and development $ 1,977 $ 1,465 $ 5,303 $ 5,481
General and administrative 7,209 1,151 16,924 3,169
Revaluation of contingent royalty obligation payable to Evolus Founders, a related party 2,300 0 11,400 0
Depreciation and amortization 3 0 7 218
Total operating expenses 11,489 2,616 33,634 8,868
Loss from operations (11,489) (2,616) (33,634) (8,868)
Other expense:        
Interest expense, net 322 2 750 4
Loss before taxes (11,811) (2,618) (34,384) (8,872)
Income tax expense 19 16 41 56
Net loss (11,830) (2,634) (34,425) (8,928)
Comprehensive loss $ (11,830) $ (2,634) $ (34,425) $ (8,928)
Net loss per share, basic and diluted (in dollars per share) $ (0.48) $ (0.16) $ (1.47) $ (0.54)
Weighted-average shares outstanding used to compute basic and diluted net loss per share (in shares) 24,768,581 16,527,000 23,417,417 16,527,000